Novel GVHD resistant humanized-PBMC mouse model for preclinical HIV research
Leo HolguiniD, Liliana Echavarria ParraiD, John C. BurnettiD
Abstract
Humanized mouse models are based on the engraftment of human cells in immunodeficient mouse strains, most notably the NSG strain. Most used models have a major limitation in common, the development of graft-versus-host disease (GVHD). GVHD not only introduces variabilities into the research data but also leads to animal welfare concerns. A new mouse strain, B6.129S-Rag2tm1Fwa CD47tm1Fpl Il2rgtm1Wjl/J which lacks Rag1, IL2rg, and CD47 (triple knockout or TKO), is resistant to GVHD development. We transplanted TKO mice with human peripheral blood mononuclear cells (PBMCs) to establish a new humanized PBMC (hu-PBMC) mouse model. A cohort of these mice was infected with HIV-1 and monitored for plasma HIV viremia and CD4+ T cell depletion. The onset and progression of GVHD were monitored by clinical signs. This study demonstrates that TKO mice transplanted with human PBMCs support engraftment of human immune cells in primary and secondary lymphoid tissues, rectum, and brain. Moreover, the TKO hu-PBMC model supports HIV-1 infection via intraperitoneal, rectal, or vaginal routes, as confirmed by robust plasma HIV viremia and CD4+ T cell depletion. Lastly, TKO mice showed a delayed onset of GVHD clinical signs ([~]21 days) and exhibited significant decreases in plasma levels of TNF{beta}. Based on these results, the TKO hu-PBMC mouse model not only supports humanization and HIV-1 infection but is also resistant to GVHD development, making this model a valuable tool in HIV research. ImportanceCurrently, there is no cure or vaccine for HIV infection, thus continued research is needed to end the HIV pandemic. While many animal models are used in HIV research, none is used more than the humanized mouse model. A major limitation with current humanized mouse models is the development of graft-versus-host disease (GVHD). Here, we show a novel humanized mouse model that is resistant to GVHD development and supports and models HIV infection comparable to well-established humanized mouse models.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A novel humanized mouse model to study mucosal HIV-1 transmission and prevention
K. Vanshylla, K. Held, … F. Klein·bioRxiv·Aug 31, 2020
- Generation of Functional Human T Cell Development in NOD/SCID/IL2rγnull Humanized Mice Without Using Fetal Tissue: Application as a Model of HIV Infection and Persistence
C. Colas, O. Volodina, … E. Haddad·bioRxiv·May 30, 2022
- Treatment of Graft-versus-Host Disease by Echinomycin in a New Humanized Mouse Model
Yan Liu, Christopher Bailey, … Yin Wang·bioRxiv·Feb 16, 2017
- Humanized FLT3 mice display enhanced tissue engraftment and support HIV-1 persistence and rebound
Patricia Resa‐Infante, Patricia Pinol, … Javier Martínez‐Picado·Translational researchPeer-reviewed·Aug 12, 2026
- Development of a low-dose PBMC humanized mouse model using CD47;Rag2;IL2rγ triple KO mice: Enhanced leukocyte reconstitution and extended experimental window
Kang-Hyun Kim, Hye-Young Song, … Sun-Min Seo·bioRxiv·Mar 30, 2026
- HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model
Alice K. Min, Behnam Javidfar, … Schahram Akbarian·Journal of VirologyPeer-reviewed·Nov 30, 2023